Enovis

Canaccord Genuity cuts Enovis Corp target price to $70

ENOVIS CORP : CANACCORD GENUITY CUTS TARGET PRICE TO $70 FROM $75

Enovis Corp's shares fell 8% to $31.51 in premarket trading after the company cut its 2025 profit forecast to $2.95-$3.10 per share, down from $3.10-$3.25. However, it raised its revenue forecast for 2025 to $2.22-$2.25 billion, up from $2.19-$2.22 billion. Brokerage Evercore ISI noted that ENOV shares are underperforming due to tariff concerns. The company reported a Q1 adjusted profit of 81 cents per share, exceeding estimates of 74 cents, but the stock has fallen approximately 22% year-to-date.

BUZZ-Enovis falls after 2025 profit forecast cut

Needham & Company LLC has lowered its price target for Enovis (NYSE:ENOV) from $64.00 to $57.00 while maintaining a "buy" rating. This new target suggests a potential upside of 72.18% from the current price of $33.11. Enovis reported earnings of $0.81 per share for the last quarter, exceeding estimates, with revenue of $558.83 million, an 8.2% increase year-over-year. Institutional investors hold 98.45% of the stock, indicating strong interest in the company.

Enovis (NYSE:ENOV) Given New $57.00 Price Target at Needham & Company LLC

Price T Rowe Associates Inc. MD has significantly reduced its stake in Enovis Co. (NYSE:ENOV) by 84.7%, selling 214,003 shares during the fourth quarter, leaving it with 38,750 shares valued at approximately $1.7 million. Other institutional investors have also adjusted their positions in Enovis. The stock has seen a decline of 3.3%, opening at $33.11, with a market cap of $1.89 billion. Enovis reported a quarterly EPS of $0.81, exceeding estimates, and analysts predict a fiscal year EPS of 2.79.

Price T Rowe Associates Inc. MD Sells 214,003 Shares of Enovis Co. (NYSE:ENOV)

Hood River Capital Management LLC acquired 661,430 shares of Enovis Co. (NYSE:ENOV) valued at approximately $29 million in Q4, according to a recent SEC filing. Other institutional investors, including Vanguard Group and DAVENPORT & Co, also increased their stakes. Enovis shares opened at $32.61, with a market cap of $1.86 billion. The company reported a quarterly EPS of $0.98, surpassing estimates. Analysts predict a 2023 EPS of 2.79, with a "buy" rating and a target price of $64.00 from Needham & Company.

Canaccord Genuity cuts Enovis Corp target price to $70

Summary

Impact Analysis